Preliminary Results of Sintilimab Plus Different Dose of IBI305 (Anti-Vegf Monoclonal Antibody) in Patients with Advanced Hepatocellular Carcinoma: A Phase Ib Study.
JOURNAL OF CLINICAL ONCOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要